The blood-brain barrier ? the effect of acidic dissociation constant on the permeation of certain sulfonamides into the brain
β Scribed by Goldsworthy, Patrick D. ;Aird, Robert B. ;Becker, Ronald A.
- Publisher
- Wiley (John Wiley & Sons)
- Year
- 1954
- Tongue
- English
- Weight
- 446 KB
- Volume
- 44
- Category
- Article
- ISSN
- 0095-9898
No coin nor oath required. For personal study only.
β¦ Synopsis
Previous studies on the blood-brain barrier which have utilized cocaine as a tracer agent have indicated that the permeability of this barrier was increased in such conditions as cerebral concussion and electric shock therapy (Aird and Strait, '44; a i r d et al., in preparation; Aird et al., '52; Strait et al., '41). Since observations based upon a single tracer agent, however, do not permit general conclusions with respect to the permeability of the blood-brain barrier, it became desirable to compare these initial results obtained with cocaine, with results obtained with other tracer agents. This, in addition to the laboriousness of the cocaine analysis, led us to initiate studies of cerebrovascular permeability with other compounds.
A review of the literature strongly suggested a similar inadequacy in the techniques used in the majority of the previous studies that have been made on the blood-brain barrier. I t would appear that studies of the permeability of this important neurophysiological mechanism, based upon single tracers selected at random, niight contribute little to our understanding of the barrier function as a whole. The ques-
π SIMILAR VOLUMES
The blood-brain barrier permeation has been investigated by using a topological substructural molecular design approach (TOPS-MODE). A linear regression model was developed to predict the in vivo blood-brain partitioning coefficient on a data set of 119 compounds, treated as the logarithm of the blo
The objective of this study was to elucidate the role of P-glycoprotein (P-gp) in restricting the blood-brain barrier (BBB) permeation of cyclic prodrugs of the opioid peptide DADLE (H-Tyr-D-Ala-Gly-Phe-D-Leu-OH). The BBB permeation characteristics of these prodrugs and DADLE were determined using a
Methotrexate was administered by intraperitoneal injection (100 mg/kg) to unirradiated mice, and to mice receiving varying doses of cranial irradiation. The animals were sacrificed 24 hours after injection, and methotrexate assays were performed on brain tissue. No methotrexate was detected in the